Unicycive Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UNCY and other ETFs, options, and stocks.About UNCY
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220.
CEOShalabh Gupta
CEOShalabh Gupta
Employees22
Employees22
HeadquartersLos Altos, California
HeadquartersLos Altos, California
Founded2016
Founded2016
Employees22
Employees22
UNCY Key Statistics
Market cap70.21M
Market cap70.21M
Price-Earnings ratio-1.15
Price-Earnings ratio-1.15
Dividend yield—
Dividend yield—
Average volume450.00K
Average volume450.00K
High today$4.00
High today$4.00
Low today$3.80
Low today$3.80
Open price$3.87
Open price$3.87
Volume385.25K
Volume385.25K
52 Week high$11.00
52 Week high$11.00
52 Week low$3.40
52 Week low$3.40
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own UNCY. This list is generated using Robinhood data, and it’s not a recommendation.